# Greene County Bancorp Inc: financial statements, quarterly

GCBC · Nasdaq · CIK 1070524 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/gcbc.md) · [Financials](/companies/gcbc/financials.md) · [Filings](/companies/gcbc/filings.md) · [Insiders](/companies/gcbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gcbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [11.2](/filings/0001140361-23-052927.md) | [13.2](/filings/0001140361-24-006651.md) | [13.8](/filings/0001140361-24-025343.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.0](/filings/0001140361-24-045754.md) | [0.7](/filings/0001140361-25-003514.md) | [0.3](/filings/0001140361-25-018061.md) | [0.1 d](/filings/0001140361-25-034176.md) | [0.4](/filings/0001140361-25-041132.md) | [0.6](/filings/0001140361-26-004189.md) | [0.9](/filings/0001140361-26-019837.md) | [1.6 d](/filings/0001140361-26-035998.md) | [1.3](/filings/0001140361-25-041132.md) | [1.3](/filings/0001140361-26-004189.md) | [1.6](/filings/0001140361-26-019837.md) | [1.6 d](/filings/0001140361-26-035998.md) |
| Net income | $m | [6.5](/filings/0001140361-24-045754.md) | [5.7](/filings/0001140361-25-003514.md) | [5.9](/filings/0001140361-25-018061.md) | [6.7 d](/filings/0001140361-25-034176.md) | [6.3](/filings/0001140361-25-041132.md) | [7.5](/filings/0001140361-26-004189.md) | [8.1](/filings/0001140361-26-019837.md) | [9.3 d](/filings/0001140361-26-035998.md) | [8.9](/filings/0001140361-25-041132.md) | [10.3](/filings/0001140361-26-004189.md) | [10.5](/filings/0001140361-26-019837.md) | [11.3 d](/filings/0001140361-26-035998.md) |
| Diluted EPS | $ per share | [0.38](/filings/0001140361-24-045754.md) | [0.34](/filings/0001140361-25-003514.md) | [0.34](/filings/0001140361-25-018061.md) | not reported | [0.37](/filings/0001140361-25-041132.md) | [0.44](/filings/0001140361-26-004189.md) | [0.47](/filings/0001140361-26-019837.md) | not reported | [0.52](/filings/0001140361-25-041132.md) | [0.60](/filings/0001140361-26-004189.md) | [0.62](/filings/0001140361-26-019837.md) | not reported |
| Basic EPS | $ per share | [0.38](/filings/0001140361-24-045754.md) | [0.34](/filings/0001140361-25-003514.md) | [0.34](/filings/0001140361-25-018061.md) | not reported | [0.37](/filings/0001140361-25-041132.md) | [0.44](/filings/0001140361-26-004189.md) | [0.47](/filings/0001140361-26-019837.md) | not reported | [0.52](/filings/0001140361-25-041132.md) | [0.60](/filings/0001140361-26-004189.md) | [0.62](/filings/0001140361-26-019837.md) | not reported |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [190](/filings/0001140361-25-018061.md) | not reported | [166](/filings/0001140361-25-003514.md) | [155](/filings/0001140361-25-018061.md) | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,688](/filings/0001140361-23-052927.md) | [2,737](/filings/0001140361-24-006651.md) | [2,872](/filings/0001140361-24-025343.md) | [2,826](/filings/0001140361-25-034176.md) | [2,875](/filings/0001140361-24-045754.md) | [2,966](/filings/0001140361-25-003514.md) | [3,008](/filings/0001140361-25-018061.md) | [3,041](/filings/0001140361-26-035998.md) | [3,059](/filings/0001140361-25-041132.md) | [3,147](/filings/0001140361-26-004189.md) | [3,181](/filings/0001140361-26-019837.md) | [3,183](/filings/0001140361-26-035998.md) |
| Total liabilities | $m | [2,504](/filings/0001140361-23-052927.md) | [2,541](/filings/0001140361-24-006651.md) | [2,672](/filings/0001140361-24-025343.md) | [2,620](/filings/0001140361-25-034176.md) | [2,658](/filings/0001140361-24-045754.md) | [2,747](/filings/0001140361-25-003514.md) | [2,779](/filings/0001140361-25-018061.md) | [2,802](/filings/0001140361-26-035998.md) | [2,810](/filings/0001140361-25-041132.md) | [2,889](/filings/0001140361-26-004189.md) | [2,914](/filings/0001140361-26-019837.md) | [2,906](/filings/0001140361-26-035998.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [184](/filings/0001140361-25-003514.md) | [195](/filings/0001140361-25-018061.md) | [199](/filings/0001140361-25-018061.md) | [206](/filings/0001140361-26-035998.md) | [216](/filings/0001140361-26-004189.md) | [218](/filings/0001140361-26-019837.md) | [229](/filings/0001140361-26-019837.md) | [239](/filings/0001140361-26-035998.md) | [248](/filings/0001140361-26-004189.md) | [258](/filings/0001140361-26-019837.md) | [268](/filings/0001140361-26-019837.md) | [278](/filings/0001140361-26-035998.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.3](/filings/0001140361-24-045754.md) | [2.0 d](/filings/0001140361-25-003514.md) | [5.6 d](/filings/0001140361-25-018061.md) | [11.1 d](/filings/0001140361-25-034176.md) | [2.2](/filings/0001140361-25-041132.md) | [5.3 d](/filings/0001140361-26-004189.md) | [7.3 d](/filings/0001140361-26-019837.md) | [13.2 d](/filings/0001140361-26-035998.md) | [7.0](/filings/0001140361-25-041132.md) | [6.4 d](/filings/0001140361-26-004189.md) | [10.7 d](/filings/0001140361-26-019837.md) | [18.3 d](/filings/0001140361-26-035998.md) |
| Capital expenditure | $m | [0.5](/filings/0001140361-24-045754.md) | [0.2 d](/filings/0001140361-25-003514.md) | [0.7 d](/filings/0001140361-25-018061.md) | [0.2 d](/filings/0001140361-25-034176.md) | [0.2](/filings/0001140361-25-041132.md) | [0.2 d](/filings/0001140361-26-004189.md) | [0.1 d](/filings/0001140361-26-019837.md) | [0.3 d](/filings/0001140361-26-035998.md) | [0.4](/filings/0001140361-25-041132.md) | [0.2 d](/filings/0001140361-26-004189.md) | [0.0 d](/filings/0001140361-26-019837.md) | [0.1 d](/filings/0001140361-26-035998.md) |
| Dividends paid | $m | [1.4](/filings/0001140361-24-045754.md) | [0.6 d](/filings/0001140361-25-003514.md) | [0.6 d](/filings/0001140361-25-018061.md) | [0.6 d](/filings/0001140361-25-034176.md) | [1.5](/filings/0001140361-25-041132.md) | [1.5 d](/filings/0001140361-26-004189.md) | [0.7 d](/filings/0001140361-26-019837.md) | [0.7 d](/filings/0001140361-26-035998.md) | [0.8](/filings/0001140361-25-041132.md) | [0.8 d](/filings/0001140361-26-004189.md) | [1.7 d](/filings/0001140361-26-019837.md) | [0.8 d](/filings/0001140361-26-035998.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-09-30) | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.0](/filings/0001140361-23-052927.md) | [17.0](/filings/0001140361-24-006651.md) | [17.0](/filings/0001140361-24-025343.md) | [17.0](/filings/0001140361-24-045754.md) | [17.0](/filings/0001140361-25-003514.md) | [17.0](/filings/0001140361-25-018061.md) | [17.0](/filings/0001140361-25-041132.md) | [17.0](/filings/0001140361-26-004189.md) | [17.0](/filings/0001140361-26-019837.md) | [17.0](/filings/0001140361-25-041132.md) | [17.0](/filings/0001140361-26-004189.md) | [17.0](/filings/0001140361-26-019837.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,025,485 at 2026-09-08, from the cover of the [10-K filed 2026-09-09](/filings/0001140361-26-035998.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.